Mayuresh Joshi of Marketsmith India explains the uncertainties around Trump's tariffs, potential sectoral impacts, and the volatility they may bring to equity markets. He suggests that while industries like autos may continue to face challenges, Indian pharmaceuticals might experience some relief. Positive domestic consumption and government investments are expected to drive growth despite global pressures.
Read More